MLchartDataset catalogue

cardioprotective agent DH001

Term · Oncology and biomedicine · MLC-T-ONC-012308

An orally bioavailable agent, with potential cardiac protective activity. Upon oral administration, cardioprotective agent DH001 may be able to reduce doxorubicin cardiotoxicity and improve cardiac function.

Table 1. Record
IdentifierMLC-T-ONC-012308
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-012308",
  "term": "cardioprotective agent DH001",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable agent, with potential cardiac protective activity. Upon oral administration, cardioprotective agent DH001 may be able to reduce doxorubicin cardiotoxicity and improve cardiac function.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/cardioprotective-agent-dh001/"
}

Record 4,248 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.